Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionadenyl-nucleotide exchange factor activity

HSPH1 HSPA4

1.47e-051582GO:0000774
GeneOntologyMolecularFunctionDNA-binding transcription factor binding

IPO13 UBXN7 HSPA4 ZMYND8

4.55e-0558284GO:0140297
GeneOntologyMolecularFunctionATP-dependent protein folding chaperone

HSPH1 HSPA4

1.09e-044082GO:0140662
GeneOntologyMolecularFunctiontranscription factor binding

IPO13 UBXN7 HSPA4 ZMYND8

1.24e-0475384GO:0008134
GeneOntologyMolecularFunctionATPase regulator activity

HSPH1 HSPA4

1.99e-045482GO:0060590
GeneOntologyMolecularFunctionprotein folding chaperone

HSPH1 HSPA4

3.64e-047382GO:0044183
GeneOntologyMolecularFunctionRNA polymerase II-specific DNA-binding transcription factor binding

IPO13 UBXN7 HSPA4

4.68e-0441783GO:0061629
DomainHSP70_peptide-bd

HSPH1 HSPA4

1.36e-051292IPR029047
Domain-

HSPH1 HSPA4

1.36e-0512922.60.34.10
DomainHeat_shock_70_CS

HSPH1 HSPA4

1.61e-051392IPR018181
Domain-

HSPH1 HSPA4

1.61e-0513921.20.1270.10
DomainHSP70_C

HSPH1 HSPA4

1.61e-051392IPR029048
DomainHSP70

HSPH1 HSPA4

2.47e-051692PF00012
DomainHSP70_3

HSPH1 HSPA4

2.80e-051792PS01036
DomainHSP70_2

HSPH1 HSPA4

2.80e-051792PS00329
DomainHSP70_1

HSPH1 HSPA4

2.80e-051792PS00297
DomainHsp_70_fam

HSPH1 HSPA4

3.15e-051892IPR013126
Domain-

FRYL IPO13

4.79e-03222921.25.10.10
DomainARM-like

FRYL IPO13

7.01e-0327092IPR011989
DomainARM-type_fold

FRYL IPO13

1.09e-0233992IPR016024
PathwayREACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE

HSPH1 HSPA4

2.62e-047352MM14948
PathwayREACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE

HSPH1 HSPA4

3.30e-048252M27250
PathwayREACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS

HSPH1 HSPA4

4.16e-049252MM14951
PathwayREACTOME_CELLULAR_RESPONSES_TO_STIMULI

HSPH1 UBXN7 HSPA4

4.33e-0450553MM15548
PathwayREACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS

HSPH1 HSPA4

5.01e-0410152M27253
PathwayREACTOME_CELLULAR_RESPONSES_TO_STIMULI

HSPH1 UBXN7 HSPA4

1.85e-0382853M27827
Pubmed

Hsp110 is a bona fide chaperone using ATP to unfold stable misfolded polypeptides and reciprocally collaborate with Hsp70 to solubilize protein aggregates.

HSPH1 HSPA4

2.23e-07310223737532
Pubmed

Prevalence and pathogenesis of Barrett's esophagus in Luoyang, China.

HSPH1 HSPA4

2.23e-07310222901192
Pubmed

A novel HSF1-mediated death pathway that is suppressed by heat shock proteins.

HSPH1 HSPA4

1.56e-06710217024176
Pubmed

Progressive aggregation despite chaperone associations of a mutant SOD1-YFP in transgenic mice that develop ALS.

HSPH1 HSPA4

3.34e-061010219171884
Pubmed

INKA2, a novel p53 target that interacts with the serine/threonine kinase PAK4.

HSPH1 HSPA4

4.09e-061110231081062
Pubmed

CBP-HSF2 structural and functional interplay in Rubinstein-Taybi neurodevelopmental disorder.

HSPH1 HSPA4

4.09e-061110236385105
Pubmed

Heat-shock protein HSPA4 is required for progression of spermatogenesis.

HSPH1 HSPA4

4.90e-061210221487003
Pubmed

Respiratory distress and early neonatal lethality in Hspa4l/Hspa4 double-mutant mice.

HSPH1 HSPA4

4.90e-061210223980576
Pubmed

Protein interactome reveals converging molecular pathways among autism disorders.

SPTBN4 FRYL IPO13 ZMYND8

1.29e-0556010421653829
Pubmed

The diverse members of the mammalian HSP70 machine show distinct chaperone-like activities.

HSPH1 HSPA4

1.88e-052310221231916
Pubmed

The B-cell antigen receptor signals through a preformed transducer module of SLP65 and CIN85.

HSPH1 HSPA4

2.05e-052410221822214
Pubmed

Systematic Proteomic Identification of the Heat Shock Proteins (Hsp) that Interact with Estrogen Receptor Alpha (ERα) and Biochemical Characterization of the ERα-Hsp70 Interaction.

HSPH1 HSPA4

2.22e-052510227483141
Pubmed

Isoform-selective Genetic Inhibition of Constitutive Cytosolic Hsp70 Activity Promotes Client Tau Degradation Using an Altered Co-chaperone Complement.

HSPH1 HSPA4

3.22e-053010225864199
Pubmed

RNF12 catalyzes BRF1 ubiquitination and regulates RNA polymerase III-dependent transcription.

HSPH1 HSPA4

9.05e-055010230413534
Pubmed

Targeting the interaction of AIMP2-DX2 with HSP70 suppresses cancer development.

HSPH1 HSPA4

1.06e-045410231792442
Pubmed

Structural and functional consequences of NEDD8 phosphorylation.

HSPH1 HSPA4

1.78e-047010234642328
Pubmed

HectD1 controls hematopoietic stem cell regeneration by coordinating ribosome assembly and protein synthesis.

HSPH1 HSPA4

2.75e-048710233711283
Pubmed

Prediction of the coding sequences of mouse homologues of KIAA gene: I. The complete nucleotide sequences of 100 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.

FRYL ZMYND8

2.75e-048710212465718
InteractionINKA2 interactions

HSPH1 HSPA4

8.93e-0529102int:INKA2
InteractionPHLPP2 interactions

HSPH1 HSPA4

1.09e-0432102int:PHLPP2
InteractionMETTL21A interactions

HSPH1 HSPA4

1.38e-0436102int:METTL21A
InteractionHPSE interactions

HSPH1 HSPA4

1.98e-0443102int:HPSE
InteractionSEC23A interactions

HSPH1 UBXN7 HSPA4

2.25e-04255103int:SEC23A
InteractionTAGLN3 interactions

HSPH1 HSPA4

2.27e-0446102int:TAGLN3
InteractionBLNK interactions

HSPH1 HSPA4

2.47e-0448102int:BLNK
GeneFamilyHeat shock 70kDa proteins

HSPH1 HSPA4

2.32e-051782583
CoexpressionGSE35435_RESTING_VS_IL4_TREATED_MACROPHAGE_UP

CFHR5 HSPA4 ZMYND8

5.05e-05200103M9542
CoexpressionELVIDGE_HIF1A_AND_HIF2A_TARGETS_UP

HSPH1 HSPA4

1.07e-0441102M7062
CoexpressionMARTINEZ_RESPONSE_TO_TRABECTEDIN_DN

FRYL HSPH1 ZMYND8

1.26e-04272103M15123
ToppCelldroplet-Lung-18m-Hematologic-myeloid-non-classical_monocyte-nonclassical_monocyte_l14|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

IPO13 UBXN7

2.93e-04116102f2bf9599040f43b5ea8724841d7b71c0a859c016
ToppCell5'-Adult-SmallIntestine-Epithelial-neuro-epithelial-EECs|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

SPTBN4 PMFBP1

5.69e-04162102478cf560ef33c5c324142c76417447d4a571a2c9
ToppCellTCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Rectal_Adenocarcinoma-7|TCGA-Colorectal / Sample_Type by Project: Shred V9

HSPH1 ZMYND8

6.86e-04178102edc76b8f15056ec1c9a1c61a048b6331a92592d6
ToppCell5'-Adult-SmallIntestine-Hematopoietic-B_cells-Naive_B|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

HSPH1 HSPA4

7.33e-04184102a068ae741889d59937690c11e0bf405481402c25
ToppCellFetal_29-31_weeks-Immune-enucleated_erythrocyte-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

HSPH1 ZMYND8

7.41e-04185102e8f7da9641b6cf1db1093b4f301ce828fd3a529c
ToppCell3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells-B_cells_L.1.5.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

HSPH1 HSPA4

7.41e-04185102e913c64f9b4873443d88dce270f0b7b6d1b4cbce
ToppCellTCGA-Uvea-Primary_Tumor-Uveal_Melanoma-Epithelioid_Cell|TCGA-Uvea / Sample_Type by Project: Shred V9

HSPH1 HSPA4

7.48e-04186102e8580a2093eb7e50aad55ec7fada850d2fed8ae1
ToppCellCOVID-19-kidney-Stressed_PCT|kidney / Disease (COVID-19 only), tissue and cell type

HSPH1 HSPA4

7.56e-04187102acd305475f3609800af0d7bc68d83ef41228080b
ToppCellfacs-Trachea-24m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l32-30|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

FRYL IPO13

7.65e-04188102c2febf9fd4632af1f922067c3a30e5c50f75f480
ToppCellCOVID-19-lung-Artery_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type

FRYL HSPH1

7.81e-0419010207b675befcd1d0a9c90cb17b5d22323468325d51
ToppCell5'-Adult-SmallIntestine-Hematopoietic-B_cells-Memory_B|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

HSPH1 HSPA4

7.89e-04191102ce0217d375af6b19252a45340b72241ea7b204d4
ToppCellhuman_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells)

HSPH1 HSPA4

7.97e-04192102916fbec1c7ab7969bda711886ac88e877e30c280
ToppCellPCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature4_(1)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung

HSPH1 HSPA4

7.97e-041921023f925a80b5e2b0577d573e88598a2984a5f6a789
ToppCellPCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature4_(1)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung

HSPH1 HSPA4

8.05e-04193102dbf0fe496254320c894568c31e5f9ce63707d1b5
ToppCellhuman_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells)

HSPH1 HSPA4

8.05e-04193102e6a688bc834f845ff64dae1be64f073eec5091a1
ToppCell5'-Adult-SmallIntestine-Hematopoietic-B_cells|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

HSPH1 HSPA4

8.14e-04194102d4bbae30b9395139c745b71f8a4a356b11223b69
ToppCellsaliva-Mild-Moderate_progression_d12-25|saliva / Compartment, severity and other cell annotations on 10x 3' data (130k)

HSPH1 HSPA4

8.22e-041951026eb123cbea7bcadbdef086a8c230f0a73caf4930
ToppCell10x3'2.3-week_17-19-Lymphocytic_B-B_lineage-immature_B_cell|week_17-19 / cell types per 3 fetal stages;per 3',per 5'

HSPH1 HSPA4

8.30e-041961029a6e4eea19348a6e3379d3b872456ab6280cb74f
ToppCell5'-Adult-SmallIntestine-Hematopoietic-T_cells-Activated_CD8_T|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

HSPH1 HSPA4

8.30e-04196102349502ed53fbf365f8f6f9e27af7f421139ae169
ToppCell10x_3'_v2v3-Neoplastic-Stem-like-NPC-like-NPC-like_OPC-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

HSPH1 HSPA4

8.39e-04197102d9a5b6171867de21d4ef12aa5a802fb4de9e0c00
ToppCell3'-Adult-Distal_Rectal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

HSPH1 HSPA4

8.47e-041981027ad7726fc405806b1d7824f58548073ea5e0c70b
ToppCell3'-Adult-Distal_Rectal-Epithelial-epithelial_progenitor_cell-TA|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

HSPH1 HSPA4

8.47e-041981021fbec311f2c987ca90a023a5989128c05aa12d5c
ToppCell3'-Adult|3' / Celltypes from developing, pediatric, Crohn's, & adult GI tract

FRYL HSPH1

8.47e-04198102302adb42089ff22fffc4f01af572ca2e151f7ce7
ToppCell3'-Adult-Distal_Rectal-Epithelial-epithelial_progenitor_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

HSPH1 HSPA4

8.47e-041981024f26a60e99f42343e5af7221723e108a1a1b7827
ToppCell3'-Adult-Distal_Rectal-Epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

HSPH1 HSPA4

8.47e-04198102ceede961ad9af6a3159db7efaa5087bf38aafc2d
ToppCell10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Stress_sig-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

HSPH1 HSPA4

8.56e-04199102c3c73c9404a73133bfad1f9ced292f5e508ef767
ToppCell10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Stress_sig|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

HSPH1 HSPA4

8.56e-04199102f3cc3cda38f78d1d12d865df339d93c5fecf19f2
ToppCellhuman_hepatoblastoma-Tumor_cells-T9|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)

HSPH1 HSPA4

8.56e-04199102e9c83555d2197b740797a9f33b64f8f7a7ba1ee2
ComputationalGenes upregulated in subsets of cells of a given type within various tumors

HSPH1 HSPA4

3.14e-045062GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_HEAT_SHOCK
ComputationalNeighborhood of RFC1

FRYL UBXN7

1.49e-0310962MORF_RFC1
DrugAC1LWLPQ

HSPH1 HSPA4

2.08e-0516102CID001778727
Drugbromotrimethyltin

HSPH1 HSPA4

4.77e-0524102CID000014015
Drug17-AAG; Up 200; 1uM; MCF7; HT_HG-U133A

HSPH1 HSPA4 ZMYND8

5.06e-051741031651_UP
Drug17-AAG; Up 200; 1uM; MCF7; HT_HG-U133A

PMFBP1 HSPH1 ZMYND8

5.33e-051771036943_UP
Drug17-AAG; Up 200; 1uM; MCF7; HT_HG-U133A_EA

HSPH1 HSPA4 ZMYND8

5.42e-05178103916_UP
Drugradicicol, diheterospora chlamydosporia; Up 200; 0.1uM; MCF7; HT_HG-U133A

HSPH1 HSPA4 ZMYND8

5.51e-051791031644_UP
DrugKNK437

HSPH1 HSPA4

5.61e-0526102CID009859662
Drug17-AAG; Up 200; 1uM; PC3; HT_HG-U133A

HSPH1 HSPA4 ZMYND8

6.47e-051891034430_UP
Druggenistein; Down 200; 10uM; MCF7; HT_HG-U133A

UBXN7 HSPA4 ZMYND8

6.89e-051931035232_DN
DrugGabazine [105538-73-6]; Up 200; 10.8uM; HL60; HT_HG-U133A

PMFBP1 HSPA4 ZMYND8

6.99e-051941031316_UP
DrugErythromycin [114-07-8]; Down 200; 5.4uM; PC3; HG-U133A

HSPH1 HSPA4 ZMYND8

7.10e-051951031928_DN
Drugprostaglandin A1

HSPH1 HSPA4

9.67e-0534102ctd:C100573
DrugAC1NRABQ

HSPH1 HSPA4

1.03e-0435102CID005287800
DrugTFE-Cys

HSPH1 HSPA4

1.03e-0435102CID000105059
DrugAC1L1K9Q

HSPH1 HSPA4

1.21e-0438102CID000005399
DrugThiostrepton

HSPH1 HSPA4

1.48e-0442102ctd:D013883
DrugMe3SnH

HSPH1 HSPA4

1.63e-0444102CID000012623
DrugAC1L1JAF

HSPH1 HSPA4

1.70e-0445102CID000004952
DrugAlbendazole

HSPH1 HSPA4

1.78e-0446102ctd:D015766
Drugsialyllactose

HSPH1 HSPA4

2.36e-0453102CID000123914
DrugAC1L1E6H

HSPH1 HSPA4

2.45e-0454102CID000002661
Drugpyrithione zinc

HSPH1 HSPA4

3.78e-0467102ctd:C010423
Druglinalool

HSPH1 HSPA4

4.37e-0472102ctd:C018584
Drugdarinaparsin

HSPH1 HSPA4

5.52e-0481102ctd:C515055
DrugIvermectin

HSPH1 HSPA4

7.59e-0495102ctd:D007559
DrugCdCl2

HSPH1 HSPA4

8.07e-0498102CID000024947
DrugHoechst 33342

HSPH1 HSPA4

1.15e-03117102CID000001464
Drugcanavanin

UBXN7 HSPA4

1.25e-03122102CID000000275
DrugAsbestos, Amphibole

HSPH1 HSPA4

1.43e-03131102ctd:D017636
DrugAC1L8WBM

HSPH1 HSPA4

1.52e-03135102CID000388647
DrugCT-26

HSPH1 HSPA4

1.61e-03139102CID003034916
DrugI EC

HSPH1 HSPA4

1.75e-03145102CID003048719
Drugmotexafin gadolinium

HSPH1 HSPA4

1.78e-03146102ctd:C437683
DrugPuromycin dihydrochloride [58-58-2]; Up 200; 7.4uM; HL60; HT_HG-U133A

HSPH1 HSPA4

1.90e-031511022448_UP
Drugsodium arsenite

HSPH1 HSPA4

1.92e-03152102CID000443495
DrugMG-132; Up 200; 21uM; MCF7; HT_HG-U133A_EA

HSPH1 HSPA4

2.15e-031611021140_UP
DrugMG-262; Up 200; 0.1uM; PC3; HT_HG-U133A

HSPH1 HSPA4

2.15e-031611027068_UP
DrugMG-262; Up 200; 0.1uM; PC3; HT_HG-U133A

HSPH1 HSPA4

2.23e-031641027079_UP
Druggeldanamycin; Up 200; 1uM; MCF7; HT_HG-U133A_EA

HSPH1 ZMYND8

2.29e-031661021066_UP
DrugZinc Acetate

HSPH1 HSPA4

2.29e-03166102ctd:D019345
Druggeldanamycin; Up 200; 1uM; HL60; HT_HG-U133A

HSPH1 HSPA4

2.32e-031671026187_UP
DrugSanguinarine [2447-54-3]; Up 200; 12uM; HL60; HT_HG-U133A

HSPH1 HSPA4

2.32e-031671022927_UP
Druggeldanamycin; Up 200; 1uM; MCF7; HT_HG-U133A

HSPH1 ZMYND8

2.37e-031691025225_UP
Drug17-AAG; Up 200; 1uM; MCF7; HT_HG-U133A_EA

HSPH1 ZMYND8

2.37e-031691021056_UP
Drug17-AAG; Up 200; 1uM; HL60; HT_HG-U133A

HSPH1 ZMYND8

2.40e-031701021167_UP
Drug17-AAG; Up 200; 1uM; HL60; HT_HG-U133A

HSPH1 HSPA4

2.45e-031721021159_UP
Drug17-AAG; Up 200; 1uM; MCF7; HT_HG-U133A_EA

HSPH1 HSPA4

2.51e-031741021063_UP
Drug17-DMAG; Up 200; 0.1uM; HL60; HT_HG-U133A

HSPH1 HSPA4

2.51e-031741022673_UP
Drug17-AAG; Up 200; 1uM; MCF7; HT_HG-U133A_EA

HSPH1 ZMYND8

2.51e-031741021044_UP
Drugradicicol, diheterospora chlamydosporia; Up 200; 0.1uM; MCF7; HT_HG-U133A_EA

HSPH1 HSPA4

2.54e-031751021057_UP
Drug15d-PGJ2; Up 200; 10uM; PC3; HT_HG-U133A

HSPH1 HSPA4

2.54e-031751021231_UP
Drug17-AAG; Up 200; 1uM; MCF7; HT_HG-U133A_EA

HSPH1 ZMYND8

2.54e-031751021006_UP
Drug17-DMAG; Up 200; 0.1uM; MCF7; HT_HG-U133A

HSPH1 HSPA4

2.57e-031761021638_UP
Drug17-AAG; Up 200; 1uM; HL60; HT_HG-U133A

HSPH1 HSPA4

2.57e-031761022666_UP
Drug17-AAG; Up 200; 1uM; MCF7; HT_HG-U133A

HSPH1 ZMYND8

2.60e-031771021643_UP
Drug17-AAG; Up 200; 1uM; HL60; HT_HG-U133A

HSPH1 HSPA4

2.60e-031771022678_UP
Drug17-AAG; Up 200; 1uM; HL60; HT_HG-U133A

HSPH1 HSPA4

2.62e-031781022685_UP
DrugPuromycin dihydrochloride [58-58-2]; Up 200; 7.4uM; PC3; HT_HG-U133A

PMFBP1 HSPH1

2.65e-031791026711_UP
Drug17-AAG; Up 200; 1uM; HL60; HT_HG-U133A

HSPH1 ZMYND8

2.65e-031791026184_UP
DrugPiperlongumine [20069-09-4]; Up 200; 12.6uM; HL60; HG-U133A

HSPH1 HSPA4

2.65e-031791021764_UP
Drug17-AAG; Up 200; 1uM; MCF7; HT_HG-U133A_EA

HSPH1 ZMYND8

2.68e-03180102947_UP
Drug17-AAG; Up 200; 1uM; MCF7; HT_HG-U133A

HSPH1 ZMYND8

2.68e-031801025223_UP
DrugChrysene-1,4-quinone [100900-16-1]; Up 200; 15.4uM; PC3; HT_HG-U133A

HSPH1 HSPA4

2.68e-031801027139_UP
Drugphencyclidine

IPO13 HSPA4

2.71e-03181102CID000006468
Drug17-DMAG; Up 200; 0.1uM; MCF7; HT_HG-U133A

HSPH1 HSPA4

2.71e-031811025573_UP
Druggeldanamycin; Up 200; 1uM; MCF7; HT_HG-U133A_EA

HSPH1 HSPA4

2.74e-031821021008_UP
Drugradicicol, diheterospora chlamydosporia; Up 200; 0.1uM; HL60; HT_HG-U133A

HSPH1 HSPA4

2.74e-031821021160_UP
Druggeldanamycin; Up 200; 1uM; MCF7; HG-U133A

HSPH1 ZMYND8

2.74e-03182102593_UP
DrugDisulfiram [97-77-8]; Up 200; 13.4uM; PC3; HT_HG-U133A

HSPH1 HSPA4

2.77e-031831022053_UP
Drug17-AAG; Up 200; 1uM; PC3; HT_HG-U133A

HSPH1 HSPA4

2.77e-031831021206_UP
Drugirinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A

FRYL ZMYND8

2.77e-031831027498_DN
Drug17-AAG; Up 200; 1uM; MCF7; HT_HG-U133A

HSPH1 ZMYND8

2.77e-031831026944_UP
Drug17-AAG; Up 200; 1uM; HL60; HT_HG-U133A

HSPH1 ZMYND8

2.77e-031831026185_UP
Drug17-DMAG; Up 200; 0.1uM; HL60; HT_HG-U133A

HSPH1 HSPA4

2.77e-031831021154_UP
Drug17-AAG; Up 200; 1uM; HL60; HT_HG-U133A

HSPH1 HSPA4

2.80e-031841022686_UP
Drugtrichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A

HSPA4 ZMYND8

2.80e-031841026916_DN
Diseasecomplement factor H-related protein 1 measurement

CFHR5 UBXN7

1.58e-0456102EFO_0600054
Diseasecerebrospinal fluid biomarker measurement

CFHR5 PMFBP1

4.63e-0496102EFO_0006794
Diseaseunipolar depression, bipolar disorder

PMFBP1 ZMYND8

1.22e-03156102EFO_0003761, MONDO_0004985
Diseaseaortic measurement

SPTBN4 HSPA4

3.10e-03251102EFO_0020865

Protein segments in the cluster

PeptideGeneStartEntry
QKLFQLQSKNMWLQQ

ANKRD30A

1321

Q9BXX3
AMEWMNNKLNLQNKQ

HSPA4

741

P34932
WMNNVMNAQAKKSLD

HSPH1

761

Q92598
NQWKQAAQMHNKNQD

FRYL

646

O94915
EENMNKNNIQLKWRN

CFHR5

511

Q9BXR6
KWHMQKMQRQQQQQQ

ZMYND8

831

Q9ULU4
NKNLAQKWLMQAQVS

IPO13

41

O94829
QVLQWQKQHQNDLKM

PMFBP1

821

Q8TBY8
KNQENQLRAQQWMQK

SPTBN4

1286

Q9H254
GQMQNKWLMINIQNV

UBXN7

161

O94888